chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This case was reported by a consumer interactive digital media and described the occurrence of shingles in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, 2 weeks after receiving Shingles vaccine, the patient experienced shingles and pain. On an unknown date, the outcome of the shingles was unknown and the outcome of the pain was recovered/resolved.   It was unknown if the reporter considered the shingles and pain to be related to Shingles vaccine.  Additional details were provided as follows: The case was reported by patient's child. The age at vaccination was not reported. The patient got Shingles vaccine and 2 weeks later got shingles. The patient had been in pain for 6 months. The reporter advised to skip the vaccine. The follow-up would not possible as no contact details were available. This case was linked with the case US2021AMR249100, reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR249100:same reporter
Information has been received from a registered nurse concerning an 8 year old male student who on 4/16/97 was vaccinated with a dose of varicella virus vaccine live. It was noted, the patient's mother reported that on 3/17/04 the patient had developed a chicken pox breakout of approximately 40 lesions. No additional information is expected. The registered nurse also reported that the patient's brother also developed a chicken pox breakout following vaccination with varicella virus vaccine live (WAES0404USA00503).
I woke up with extreme pain in the left arm.  I had no fever or other symptoms, but the pain worsened throughout the day.  I sought treatment from my doctor as soon as I could get an appointment the next week.  He did an xray which showed no shoulder damage, and prescribed a round of cortisone.
client received injection at approximately 10:45 am. She was sent to the waiting area for her 15 minutes of monitoring and notified the room monitor at 10:50 that she needed to lie down. The  nurse was summoned and observed fine tremors; client stated she gets this with injectable meds , but that usually taking gabapentin 300 mg 1 hour prior helps. She was adamant that an ambulance not be called. Taken by wheelchair to first aid room  and  she lay down on the cot. Advised that if at any point she was unable to converse and remain alert and oriented that an ambulance would be summoned. She continued to have tremors and spasms of varying intensity on and off until approximately 11:10.  Vitals remained stable, and she was able to continue to converse. Monitored until 11:40,. At that point she stated she felt completely normal and was escorted to her ride. Advised to check in with regular provider, and to arrange booster at provider's office. She will call if she experiences any further reactions outside of the  expected side effects.
03/19/14 Patient experienced warm, red, sore area of inoculation. Hard in center. Called me and called PCP. PCP advised to take BENADRYL 50 mg. Better today 3/20 - redness subsiding, less sore.
FEVER BEGAN.  30 MINUTES LATER CHILLS BEGAN. WHOLE BODY SHAKING. COVERED MYSELF WITH HEAVY BLANKETS.  CHILLS SUBSIDED AFTER 1 HOUR.  FEVER SUBSIDED AFTER 4 HOURS.  EXHAUSTED WITH BODY ACHES FOR REMAINDER OF THE DAY.
The evening of the vaccines child started limping. Right leg from groin to knee swollen with redness and warmth present. Right thigh left above knee measures 32 1/4 cm  - 31 cm - R=28 cm-  L253/4 cm - R 26 cm - L 243/4
Sore arm with mild pain, redness, hot to the touch, painful to touch, slight swelling around site of injection for four days after receipt.
This spontaneous report was received from a registered nurse regarding four unspecified patients of unknown age and gender. The patients' pertinent medical history, drug reactions or allergies and concomitant therapies were not reported. On unknown dates, the patients were vaccinated with an improperly stored doses of VARIVAX (Merck) (dose and route were not reported, lot # L006385, expiry date 25-FEB-2017). There were no adverse effects reported. Follow up information was received on 02-OCT-2015. On 02-OCT-2015, a call was placed to the registered nurse and went directly to voice mail. A voice mail message was left requesting the nurse to return the phone call and requesting also for patients identifiers, lot number and expiration date and date of vaccination. All telephone attempts to obtain follow-up information have been unsuccessful. Follow up information has been received from the reporting nurse on 08-OCT-2015 and refers to an 18 year old patient of unknown gender. On 17-AUG-2015, the patient was vaccinated with a dose of improperly stored VARIVAX (Merck). The temperature excursion had place on 09-AUG-2015. This is one of several reports received from the same source. Additional information has been requested. Patient details and narrative were updated.
This spontaneous report was received from a healthcare professional, refers to an unknown number of patients of unknown age and gender. The patient's medical history and concurrent conditions were not reported. The healthcare professional informed that on an unknown date, the patients were vaccinated with improperly stored doses of GARDASIL, lot # J011272, expiration date: 21-APR-2016 (dosage, and route were not reported). Concomitant therapy was not reported. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
A health professional report has been received. The report concerns a 10 year old, female consumer, who had been receiving Nasal FLUMIST QUADRIVALENT (INTRANASAL). FLUMIST QUADRIVALENT (INTRANASAL) started on 23-Dec-2013. The reporter stated inadvertently gave expired FLUMIST QUADRIVALENT which started on 23-Dec-2013. The outcome of the event of gave expired FLUMIST QUADRIVALENT is unknown. The report was considered to be non-serious by the reporter.
Sore left injection site arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Sore left injection site arm) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025L20A and 030L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 02-Jan-2021, the patient experienced VACCINATION SITE PAIN (Sore left injection site arm). At the time of the report, VACCINATION SITE PAIN (Sore left injection site arm) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No concomitant medication information was provided. No treatment medication information was provided. On 27-Jan-2021 patient received second Moderna Covid-19 vaccine. The patient reports a sore left injection site arm and got chills. Patient had low energy for a couple of days. Patient had chin implant and after second Moderna Covid-19 vaccine the left side of face went numb. In early June patient started to develop knots all over her lower leg.  On 01-Jun-2021 patient had generally felt bad since, felt very tired and sluggish. It was reported that patient visited Doctor and Dermatologist and they feel that patient had a secondary inflammation. She was diagnosis with erythema nodosum.   This case was linked to MOD-2021-322443 (Patient Link).
Patient was hospitalized due to breakthrough infection. Patient received Pfizer vaccine (2nd dose in series) on 04/06/2021. Patient was hospitalized from 01/07/2022 - 01/20/2022. Below is copied from discharge summary:  Hospital Course:  Patient is a 90 y/o F with Hx of dementia, hypothyroidism, HTN, HLD and GERD who presents from Nursing and Rehab who presents due to abnormal labs today-BUN of 90, admitted as OBS for further management.   # AKI on CKD -In context of Covid 19  -Gentle hydration in setting of concomitant HF  -Avoid nephrotoxins   #COVID 19: - Stable with low flow O2 by NC - Isolation, stop steroids - followed closely    # L pleural effusion: -Small - Monitored     # Leukocytosis: -WBC of 14 -Steroid related ? -Afebrile -Xray w/o new infiltrate -UA/UCx pending -Monitor off Abx     Hypocalcemia: -7.8 - Corrects with alb  -Monitor   HLD: -Resume statin   Neuropathy: -Resume gabapentin   Hypothyroidism: -Resume synthroid   GERD: -Resume ppi   Dementia: -Supportive care   Moderate protein calorie malnutrition  -BMI of 16 -Start supplement    discussed with patient's daughter over the phone. Comfort care. No blood draws.   Consulted hospice   To SNF with hospice following
Due to the pandemic/ did not get his second dose/first dose/ January/2020; This case was reported by a consumer via call center representative and described the occurrence of social problem in a 66-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of fatigue (received 1st dose on 20th January 2020 and also experienced achy, refer case US2021117069).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced social problem. On an unknown date, the outcome of the social problem was unknown.  The additional details were provided as follow: The case was reported by the patient itself. Till the time of reporting, the patient did not receive 2nd dose of Shingrix due pandemic. The patient inquired if he needs to get his 2nd dose of Shingrix or needed to start over. No consent given to follow up with his healthcare professional. The reporter did not consent to follow up.
Pain at site, severe nausea, headache, chills, fatigue, tired, stomach irritated.
Patient did not have an adverse reaction. Instead, patient registered to receive the Moderna COVID-19 vaccination series with an incorrect date of birth making him 18 when he is 17 years of age.  When a person registers on the county's website one of the first questions they are asked is if they are over 18 and have to enter DOB to prevent those under 18 from registering. If a person selects "no" the system will not allow them to proceed with the registration process. Additionally, when patients arrive to their appointments, they are asked to verify their personal information. Patient did not make any corrections to his date of birth until after his second dose was administered.
Deviation of the corner of the mouth on the left side, watery left eye, heavy tongue, loss of strength in the left hand and speech problems.
she took the Pneumococcal 13 conjugant vaccine and got pneumonia soon after; she took the Pneumococcal 13 conjugant vaccine and got pneumonia soon after; This is a spontaneous report from a contactable consumer (patient). A female patient (Age: 68; Unit was not reported) received pneumococcal 13-valent conjugate vaccine (diphtheria crm197 protein) (trade name and manufacturer were not reported; Lot number and expiration date were not reported) on an unspecified date in 2013 as a single dose, with route of administration unspecified, for immunization. Medical history included non-Hodgkin's lymphoma; low immunity; and follicular slow growing lymph node removal in 2006. The patient's concomitant medications were not reported. On an unspecified date in 2013, the patient had received pneumococcal 13-valent conjugate vaccine (diphtheria crm197 protein), and got pneumonia soon after. The outcome of the event was unknown.
Diarrhea, Fatigue, Muscle Aches, nausea, stomach cramps, headache.
Starting 06/04/2022, in the evening, I developed a mild dry throat and then developed aches and fatigue. I went to bed and had some night sweats and woke up feeling off. So the following morning I woke up and took a test and it was positive. I called my doctor and they prescribed me PAXLOVID and SYMBICORT, and I picked them up and started them that day (06/05/2022). I progressively got more tired that day and had night sweats that night as well. Monday (06/06/2022) I was tired and achy most of the day and was staying in my room mostly. I started feeling better by 06/07/2022 and remained stable through the end of the week. I felt better by that weekend (tested negative on 06/11/2022) and was outside around the house. This morning (06/13/2022) I felt a dry throat and tested myself which was positive. I'm getting a little fatigued and congested at this time.
On 12/8/00, child broke out in hives from head to toe and itching, was sleepy and dizzy. Benadryl was given that evening and was seen by MD on 12/9/00 and given Allegra. On 12/11/00, rash has almost disappeared and 12/9/00 sleepiness and dizziness has decreased, Is recovering.
This spontaneous report was received from a nurse practitioner refers to a patient of unknown gender and age. Information regarding his medical history, concurrent condition and concomitant therapy was not provided. Reporting nurse practitioner stated that she noted on an unspecified date, the patient may have been vaccinated with a third dose of M-M-R II (inappropriate schedule of drug administration). No adverse effect was reported. Additional information has been requested.
This spontaneous report was received from a physician via other company and refers to a 4-month-old female patient. The patient was normal and she was a vaginally delivered term baby with no problems. The patient had no relevant concomitant medications or past drug history. On 29-DEC-2016 at 16:30, the patient was accidentally vaccinated with a 0.5 ml dose of GARDASIL, lot # M028323 with expiry date on 26-SEP-2018 (indication was reported as accidental administration and route of administration was reported as injection), which was intended for another, 13-year-old patient. The physician did not observe any adverse reactions after the vaccination. At the time of this report the patient was breast feeded calmly. Additional information has been requested.
Mother states client c/o neck pain upon awakening 3/18/11, more towards back of neck. On 3/19/11 client c/o neck pain had worsened. She took 1 dose of Ibuprofen (400mg) on 3/19/11 for neck pain. Later that night on 3/19/11 she c/o (R) shoulder pain & pain at injection site. On 3/21/11 client had arm numbness & tingling sensation in (R) arm from shoulder to elbow. Now on 3/23/11 in the night approx 12:30 am, client c/o entire (R) arm being numb & tingly down into her fingers. She describes the feeling as if it's asleep & that tingling sensation when you don't want anything or anyone to touch it (like when your leg or foot goes asleep). She took 1 dose of Ibuprofen (400mg) the night of 3/23/11. She did say that neck hurts worse when she looks down (chin to chest). Denies arm & fingers being blue & no edema or fever. RN advised for client to be seen at her pediatrician's office-Dr.
usual soreness at the site / area was sore again; Red outline around the injection site / getting bigger; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (usual soreness at the site / area was sore again) and VACCINATION SITE ERYTHEMA (Red outline around the injection site / getting bigger) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 28-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (usual soreness at the site / area was sore again) and VACCINATION SITE ERYTHEMA (Red outline around the injection site / getting bigger). At the time of the report, VACCINATION SITE PAIN (usual soreness at the site / area was sore again) and VACCINATION SITE ERYTHEMA (Red outline around the injection site / getting bigger) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications reported.  No treatment information was provided. Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) in response to the event was not applicable.
Patient returned for second pfizer vaccine today. When I attempted to give the vaccine, patient pulled away from the injection, and the full dose was not administered. I called the CDC and the recommendation was that if a. equipment failure b. patient pulled away 3. leakage that you should repeat the dose immediately at normal intervals. The patient and his sibling were both coming in for Pfizer vaccines and they both left before I called the CDC to get this recommendation. I have submitted all workplace required documentation and am submitting this VAERs before reaching out to the patient.
After eating, I got up to put something back in the refrigerator and started feeling really nauseous and cold. Then it felt like the world was swaying like I was underwater and colors looked really bright, i felt really dizzy. I laid down on the couch and waited a couple minutes till everything was kind of normal. I still feel nauseous but the dizziness is almost gone.
The patient passed out after receiving his first Pfizer vaccine on 10/15/2021, a Friday evening. He slumped in the chair in the Observation area, and was quickly attended to by the Pharmacist and the Store manager. We immediately called 911, and then laid him down across the chairs to get his head and feet at the same elevation, at which time he quickly regained  consciousness. We stayed by his side until the EMS arrived, and he was taken away on their stretcher. Hi wife reported that they took him to a medical facility and he had a follow-up with his Dr on the following Monday.
Injection site soreness. Immediately. Soreness and stiffness of arm and injection site lasting several days.  Headache a few hours after injection. Lastly 24 hours  Tiredness and muscle fatigue.  12 hours after injection. Lasting several days
3 hours after receiving the vaccine I started with tingling in my leg and the swollen ankle area, it was tingling until 7am of 09/02/2021. It was mild, it did not affect my walking or has turned red or hot, only the tingling. This has never happened to me before based on my condition of bilateral venous insufficiency.
4x6 pruritic area of redness, warm to the touch and mild edema. On 5/23/15 pt reports continued sx's of red and white patchy bumps (not fluid or pus filled) and pruritis. Since sx's have persisted for three months, advised f/u with PCP for further evaluation.
PATIENT MADE AN APPOINTMENT FOR A SECOND DOSE MONOVALENT VACCINE. PATIENT WAS ELIGIBLE FOR A BIVALENT BOOSTER ONLY.
Left arm swollen to elbow and up to scapula. Denies fever, complains of itching, redness, swelling, warm, red. Started 3/28. Started going down 3/29/2004.
approx 1wk p/vax pt exp stomach cramps, low-grade fever (99-100), myalgia, myasthenia, twitching especially in legs, cheeks, & neck, & soreness @ the balls of both feet;this is 1 of 2 pt from site to have adverse exp p/vax;
Pt began having urticaria day 28 after vaccination per mom and pt report. she first saw allergist Dec of 2019 for recurrent urticaria and allrgic rhinitis sx's that were treated with antihistamines.   I do not have further records from allergy, but Mom reported to my nurse that pt developed chronic urticaria/suspected autoimmune disorder. Jan of this year pt was diagnosed with type 1 diabetes mellitis.
approx 48hrs p/vax devel facial swelling w/red blotches, the noc a/had severe vomiting & diarrhea;illness lasted 5 days;
Severe itching on vaccination site.  Redness, swelling, and bumps.  Benadryl relieves the itching, but then more itching on other parts of my body.  I am on my way to buy Benadryl tablets to see if itching will stop. Since applying Benadryl topically it seems to relieve the  severity of the itchiness elsewhere.
Impaired vision the evening of the vaccine. Described as wavy or scrambled blind spots. Person thought they were getting a migraine with aura, but never got the migraine/headache.; Impaired vision the evening of the vaccine. Described as wavy or scrambled blind spots. Person thought they were getting a migraine with aura, but never got the migraine/headache.; This is a spontaneous report from a non-contactable consumer. A 34-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 03Apr2021 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Medication within two weeks prior to vaccination was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03Apr2021, the patient experienced impaired vision the evening of the vaccine. It was described as wavy or scrambled blind spots. The patient thought they were getting a migraine with aura, but never got the migraine/headache. The patient went to bed soon after the impaired vision started and the adverse event ended. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events  impaired vision the evening of the vaccine, described as wavy or scrambled blind spots was resolved on an unknown date in Apr2021at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Intermittent, itchy, pink skin rash patches, daily, starting 11 days after the vaccine, and still continuing to this day (28 days), although fewer than initially.
Admitted on 8/9/21. Had first dose of Moderna vaccine on 7/28/21. Presents with SOB and dyspnea which is worse with exertion x 3 days. Tested positive for COVID on 8/9 at urgent care and sent to ED. Diagnosed with acute respiratory failure and bilateral pneumonia due to COVID viral infection. Treated with COVID protocol, antibiotics, steroids, remdesivir and oxygen. Patient condition improved and he was discharged on 8/15/21.
Severe pruritus with whelps one day prior to receiving vaccine followed by severe arthralgias of knees and hips.
pt recvd vax; few min following inject; pt exp itching; following morning pt devel red welts over trunk & legs; pt treated w/ diphenhydramine HC1;
Large very red swollen arm at injection site day after shot. Also heavily bruised at inject site. Developed very bad cold, sinus infection 2 days after shot. recovery is TBD. Pt still on antibiotics.,
This spontaneous report was received from a medical assistant, referring to a 12 month old patient of an unknown gender. The patient's medical history, concurrent conditions or concomitant medication were not reported. On 05-JUN-2018, the patient was vaccinated with improperly stored doses of Oka/Merck VARIVAX lot # N024568, expiration date 07-SEP-2019 or lot # N029631, expiration date 23-OCT-2019, for prophylaxis (dosage information and route of administration were not informed). Other suspect therapies included MERCK STERILE DILUENT lot # M029682, expiration date 12-JAN-2019. No adverse effects were reported. It was also reported that the temperature and time frame were -14°C to -10°C (-12.7°C) for 20 minutes. There was no previous temperature excursion. A "data logger" was involved. This is one of several cases from the same reporter. Sender's Comments: US-009507513-1806USA012318:Original Case : 1806USA005053 US-009507513-1806USA012317:Original Case : 1806USA005053 US-009507513-1806USA012319:Original Case : 1806USA005053 US-009507513-1806USA005053:Original Case : 1806USA005053.
Pain in right shoulder around rotator cuff due to vaccination inflammation - not any better after 12 months of pain.  Since receiving the 2nd dose (11/22/2021) patient has maintained a journal of "spike headaches" if heart rate is above 150 bpm for more than 5 minutes.